Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

18F-FDG PET/CT in Erdheim-Chester Disease: Imaging Findings and Potential BRAF Mutation Biomarker.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine - 1 May 2018

Young Jason R, Johnson Geoffrey B, Murphy Robert C, Go Ronald S, Broski Stephen M

Abstract excerpt

The purpose of this study was to evaluate 18F-FDG PET/CT for the diagnosis, management, and treatment of Erdheim-Chester disease (ECD). Methods: Our institutional database (2007-2017) was retrospectively reviewed for patients with pathologically proven ECD. A chart review yielded demographics, clinical information, and 5 categories of clinical impact. Two radiologists in consensus interpreted the images. Imaging...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Databases, Factual
Share to Erdheim-Chester Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fluorodeoxyglucose F18

Share to Image Processing, Computer-Assisted

Share to Positron Emission Tomography Computed Tomography

Share to Proto-Oncogene Mas

Share to Proto-Oncogene Proteins B-raf

Share to Radiopharmaceuticals

Source

Identifiers

PMID: 29097410
DOI: 10.2967/jnumed.117.200741

Genes

BRAF
ECD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

18F-FDG PET/CT in Erdheim-Chester Disease: Imaging Findings and Potential BRAF Mutation Biomarker.PMID 29097410Read ↗

The role of 2-[18F]FDG PET/CT in Erdheim-Chester disease.Semantic proximity Read ↗

Skeletal involvement in Erdheim-Chester disease: Multimodality imaging features and association with the BRAFV600E mutation.Semantic proximity Read ↗

Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era.Semantic proximity Read ↗

Erdheim-Chester Disease Successfully Treated with Front-Line Single-Agent Dabrafenib.Semantic proximity Read ↗

Erdheim-Chester disease.Semantic proximity Read ↗

[Erdheim-Chester disease initially discovered at extraskeletal locations: a clinicopathological analysis of four cases].Semantic proximity Read ↗

[Erdheim-Chester disease: a clinicopathological analysis of 16 cases].Semantic proximity Read ↗

Recent advances in therapeutic strategies of Erdheim-Chester disease.Semantic proximity Read ↗

Case report of a patient with Erdheim-Chester disease presenting with neuro-endocrine symptoms and negative for BRAF mutation.Semantic proximity Read ↗

Case Report: When an unknown fever unmasks Erdheim-Chester disease: a case showing the use of multimodality imaging and the successful interferon alpha therapy.Semantic proximity Read ↗

Case Report: When an unknown fever unmasks Erdheim-Chester disease: a case showing the use of multimodality imaging and the successful interferon alpha therapy.Semantic proximity Read ↗

Erdheim-Chester disease harboring the BRAF V600E mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.